Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;53(1):1676-1687.
doi: 10.1080/07853890.2021.1980819.

Pathophysiology of respiratory failure in patients with osteogenesis imperfecta: a systematic review

S Storoni  1 , S Treurniet  1 , D Micha  2 , M Celli  3 , M Bugiani  4 , J G van den Aardweg  5 , E M W Eekhoff  1
Affiliations

Pathophysiology of respiratory failure in patients with osteogenesis imperfecta: a systematic review

S Storoni et al. Ann Med. 2021 Dec.

Abstract

Introduction: Respiratory failure is a major cause of death in patients with Osteogenesis Imperfecta. Moreover, respiratory symptoms seem to have a dramatic impact on their quality of life. It has long been thought that lung function disorders in OI are mainly due to changes in the thoracic wall, caused by bone deformities. However, recent studies indicate that alterations in the lung itself can also undermine respiratory health.

Objectives: Is there any intrapulmonary alteration in Osteogenesis Imperfecta that can explain decreased pulmonary function? The aim of this systematic literature review is to investigate to what extent intrapulmonary or extrapulmonary thoracic changes contribute to respiratory dysfunction in Osteogenesis Imperfecta.

Methods: A literature search (in PubMed, Embase, Web of Science, and Cochrane), which included articles from inception to December 2020, was performed in accordance with the PRISMA guidelines.

Results: Pulmonary function disorders have been described in many studies as secondary to scoliosis or to thoracic skeletal deformities. The findings of this systematic review suggest that reduced pulmonary function can also be caused by a primary pulmonary problem due to intrinsic collagen alterations.

Conclusions: Based on the most recent studies, the review indicates that pulmonary defects may be a consequence of abnormal collagen type I distorting the intrapulmonary structure of the lung. Lung function deteriorates further when intrapulmonary defects are combined with severe thoracic abnormalities. This systematic review reveals novel findings of the underlying pathological mechanism which have clinical and diagnostic implications for the assessment and treatment of pulmonary function disorders in Osteogenesis Imperfecta.KEY MESSAGESDecreased pulmonary function in Osteogenesis Imperfecta can be attributed to primary pulmonary defects due to intrapulmonary collagen alterations and not solely to secondary problems arising from thoracic skeletal dysplasia.Type I collagen defects play a crucial role in the development of the lung parenchyma and defects, therefore, affect pulmonary function. More awareness is needed among physicians about pulmonary complications in Osteogenesis Imperfecta to develop novel concepts on clinical and diagnostic assessment of pulmonary functional disorders.

Keywords: Osteogenesis Imperfecta; lung pathophysiology; pulmonary function; respiratory mechanics; thoracic skeletal changes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1.
Figure 1.
Flow diagram of the systematic review following the PRISMA guidelines.
See this image and copyright information in PMC

References

    1. Sillence DO, Senn A, Danks DM.. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16(2):101–116. - PMC - PubMed
    1. van Dijk FS, Cobben JM, Kariminejad A, et al. . Osteogenesis imperfecta: a review with clinical examples. Mol Syndromol. 2011;2(1):1–20. - PMC - PubMed
    1. Van Dijk FS, Sillence DO.. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164(6):1470–1481. - PMC - PubMed
    1. Monti E, Mottes M, Fraschini P, et al. . Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag. 2010;6:367–381. - PMC - PubMed
    1. Marini JC, Forlino A, Bächinger HP, et al. . Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052. - PubMed

Publication types